# Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)

> **NCT02840695** · — · COMPLETED · sponsor: **Uppsala University** · enrollment: 9858 (actual)

## Conditions studied

- Ankylosing Spondylitis
- Spinal Fractures

## Interventions

- **DRUG:** bDMARD treatment

## Key facts

- **NCT ID:** NCT02840695
- **Lead sponsor:** Uppsala University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2015-12
- **Final completion:** 2017-10-24
- **Target enrollment:** 9858 (ACTUAL)
- **Last updated:** 2017-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02840695

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02840695, "Effect of Biological Disease Modifying Anti Rheumatic Drug (bDMARD) Treatment on Spinal Fracture Incidence in Patients With Ankylosing Spondylitis (AS)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02840695. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*